Bank of New York Mellon’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-108,310
Closed -$2.54M 4338
2023
Q3
$2.54M Buy
108,310
+3,672
+4% +$88.7K ﹤0.01% 2677
2023
Q2
$2.58M Buy
104,638
+6,986
+7% +$173K ﹤0.01% 2693
2023
Q1
$2.45M Buy
97,652
+2,604
+3% +$64.5K ﹤0.01% 2688
2022
Q4
$2.3M Buy
+95,048
New +$2.28M ﹤0.01% 2781

Other funds holding IBDX

Bank of New York Mellon's IBDX Position: Q4 2023 in Review

Bank of New York Mellon sold out of iShares iBonds Dec 2032 Term Corporate ETF (IBDX) in Q4 2023, closing a stake of 108,310 shares — an estimated $2.54M sold.

Bank of New York Mellon first reported a position in IBDX in Q4 2022 and held it in 4 quarters. The position peaked at $2.58M in Q2 2023. 84 funds tracked by Wall St. Rank hold IBDX as of Q4 2023.

  • Bank of New York Mellon reported no remaining iShares iBonds Dec 2032 Term Corporate ETF position as of Q4 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 108,310 iShares iBonds Dec 2032 Term Corporate ETF shares in Q4 2023, an estimated $2.54M.
  • Bank of New York Mellon first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and held it in 4 quarters.
  • Bank of New York Mellon's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $2.58M in Q2 2023.
  • 84 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q4 2023.

Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.